[Quick Take] Interview with Richard Davis, Managing Director at Needham & Co.
Over the last five years, Needham & Co. has been one of the top five underwriters of IPOs in the technology industry – specifically software. […]
Endologix Q4: Smooth Sailing
Endologix, developer of Powerlink, a treatment for abdominal aortic aneurysms (AAA), posted another strong quarter. I am an unabashed fan of the company which, in […]
OneMedForum 2009: Presenting Companies Schedule
The OneMedPlace finance conference for emerging med tech companies, the OneMedForum, will be held January 13-14 in San Francisco. Our objective has been to identify […]
A Long Time Coming: Electro-Optical Sciences to Announce MelaFind Trial Results
Irvington-NY based Electro-Optical Sciences (EOS), developer of The MelaFind System, a handheld imaging device that detects melanomas at an early stage, announced last week that […]
Minrad and Piramal to Merge
Piramal Healthcare Limited will acquire Minrad International for $.12 per share plus the assumption of debt. The total transaction, valued at approximately $40 million, is […]
NovaDel: Longs May Finally Get a Good Night’s Sleep
The FDA has approved NovaDel’s Zolpimist, an oral spray for the short-term treatment of insomnia. Zolpimist contains zolpidem tartrate, the same active ingredient found in […]
[Incubator Profile] UAMS BioVentures
OneMedPlace would like to welcome UAMS BioVentures as a founding member of our Portfolio Development Group. BioVentures, will discuss its innovative business practices at the […]
[Company Profile] OptiNose
OptiNose’s breath-actuated devices deliver intranasal drugs to targeted regions of the nasal cavity, including the sinuses and the olfactory region, without lung deposition, a major […]
AngioDynamics’ NanoKnife: “Unique and Remarkable” Absence of Post-Operative Pain
AngioDynamics announced the use of its Irreversible Electroporation (IRE) technology on a lymph node metastasis and the first lung lesion case. The procedures were judged […]
CompuMed Secures $4 Million for Strategic Initiatives
CompuMed has secured a $4 million line of credit, allowing the telemedicine company to pursue strategic initiatives even in this challenging financing environment. The funds […]